Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-03-17

FDA Approved: SILENOR — Original Application (Currax Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved Silenor (doxepin hydrochloride) through an original NDA by Currax Pharmaceuticals LLC for the treatment of insomnia in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silenor (Doxepin hydrochloride)

Snippet

ORIG AP for SILENOR (DOXEPIN HYDROCHLORIDE)